Directory

Greenyarn strives to produce revolutionary products using environmentally friendly process and materials. Greenyarn aspires to be the leading brand name for new eco-friendly textile and apparel.
Through continuous research and development, Greenyarn offers eco-friendly fabric to satisfy the need for a new age fabric. Everything we make is made from all-natural ingredients; we do not support industry harmful to the environment, and manufacturing process are sustainable.

FEI is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. FEI's imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Angstrom (one-tenth of a nanometer) level.

ExQor's patented bio-nanotransport platform enables delivery of many different types of drugs throughout the body, including the brain. Uniquely and unlike almost all other nano-particles, ExQor's could also become a powerful new therapeutic in its own right.

ExQor's multiple patents cover Clathrin, a vitally essential protein responsible for transporting a very broad variety of substances—from cholesterol to neurotransmitters—to the interior of cells. Clathrin is also implicated in viral diseases, like HIV.

Evolved Nanomaterial Sciences, Inc. is an emerging innovator in the field of chiral separations science.We have developed a number of unique and powerful technologies for the resolution of chiral molecules. ENS enables previously unattainable molecular separations, delivers unprecedented selectivity and scalability, and dramatically simplifies the research and analysis process. We have already expanded the chemical range of chiral chromatography to include low molecular weight compounds, commonly used in chiral synthesis, crystallographic resolution and analysis.

ETEX Corporation has developed, manufactured and marketed proprietary, nanocrystalline calcium-phosphate-based biomaterials that promote the repair and regeneration of bone damaged by trauma or disease. Our experience and expertise in bone biology and biomaterials is the foundation for a robust, innovative, market-driven product pipeline.

Provides instrumentation and equipment for volume production of MEMS devices. Scalable system architecture supports MEMS testing from development through production. Specializes in test technology for inertial, pressure and optical MEMS.

Ensemble Discovery is developing a new class of therapeutics - the Ensemblins™, orally bioavailable small molecule macrocyclic compounds that have the potential to behave like biologics and can disrupt protein-protein interactions. We have two complementary platforms that provide access to these molecules. Firstly, we use our proprietary DNA-Programmed Chemistry™ (DPC™) platform to generate hundreds of thousands of these molecules for rapid screening. Secondly, we have highly developed methods for the synthesis of Ensemblins as discrete molecules using conventional chemistry.

Palmetto Pharmaceuticals is a drug development company recently formed from the leveraged purchase of substantially all of the assets of eNOS Pharmaceuticals of Cambridge,MA and certain intellectual property assets of Angiogenix,Inc of San Francisco,CA. These two companies had done extensive pre-clinical and clinical work on the development of combination therapies that addressed the improved endothelial function and enhanced blood flow resulting when the amino acid L-arginine was administered with statins.

Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). The company focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Their NanoCrystal® technology is a proven innovation for poorly water-soluble compounds, manufactured to the nanoscale it has five licensed products commercialized to date.

Founded in 1997 as a spin-off from the MIT Media Lab, E Ink Corporation is the world-leading developer and provider of electronic paper displays (EPD) to the market. Purchased in late 2009 by Prime View International (now E Ink Holdings, Inc.), E Ink Corporation is now the world's largest supplier of displays to the eBook industry. Products made with E Ink electronic paper displays possess attributes that enable new advancements in the mobile electronics market: